This brand name is authorized in Canada, Estonia, Croatia, Italy, Japan, Poland, Romania, Turkey
The drug NGENLA contains one active pharmaceutical ingredient (API):
1
Somatrogon
UNII 6D848RA61B - SOMATROGON
|
Somatrogon is a glycoprotein comprised of the amino acid sequence of hGH with one copy of the of C-terminal peptide (CTP) from the beta chain of human chorionic gonadotropin (hCG) at the N-terminus and two copies of CTP (in tandem) at the C-terminus. The glycosylation and CTP domains account for the half-life of somatrogon, which allows for weekly dosing. Somatrogon binds to the GH receptor and initiates a signal transduction cascade culminating in changes in growth and metabolism. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
NGENLA Solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
H01AC08 | H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01A Anterior pituitary lobe hormones and analogues → H01AC Somatropin and somatropin agonists | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: CA | Health Products and Food Branch | Identifier(s): 02521679, 02521687 |
Country: EE | Ravimiamet | Identifier(s): 1875900, 1875911 |
Country: IT | Agenzia del Farmaco | Identifier(s): 049913015, 049913027 |
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 2412404G1024, 2412404G2020 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100465918, 100465925 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W68503001, W68504001 |
Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8681308951007, 8681308951106 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.